Partner Sheila Swaroop was quoted in “Generic Drug Decisions Stall as Virus Forces Patent Court Delays,” which was published in Bloomberg Law.
Excerpt: The goal has “consistently” been to resolve the litigation within the time frame of those FDA stays, “but right now the courts and the litigants are in a unique situation,” Swaroop said.
